Isoflurane induces second window of preconditioning through upregulation of inducible nitric oxide synthase in rat heart

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 289, Issue 6 58-6, 2005, Pages

  Wakeno Takahashi, Mayu ^a   Otani, Hajime ^a   Nakao, Shinichi ^a   Imamura, Hiroji ^a   Shingu, Koh ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Cardioprotection; Infarct; Ischemic preconditioning; Volatile anesthetics

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; INHALATION ANESTHETIC AGENT; ISOFLURANE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INDUCTION; HEART; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART PROTECTION; HYPOTHESIS; MALE; MINIMUM LUNG ALVEOLUS CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION;

ADMINISTRATION, INHALATION; ANESTHETICS, INHALATION; ANIMALS; CARDIOTONIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART; ISCHEMIC PRECONDITIONING, MYOCARDIAL; ISOFLURANE; MALE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, SPRAGUE-DAWLEY; UP-REGULATION; VENTRICULAR FUNCTION, LEFT;

EID: 28144462502     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00400.2005     Document Type: Article

References (34)

1. Baxter GF, Goma FM, and Yellon DM. Characterisation of the infarct-limiting effect of delayed preconditioning: time course and dose-dependency studies in rabbit myocardium. Basic Res Cardiol 92: 159-167, 1997.
2. Bolli R. The early and late phases of preconditioning against myocardial stunning and the essential role of oxyradicals in the late phase: an overview. Basic Res Cardiol 91: 57-63, 1996.
3. Bolli R, Dawn B, Tang XL, Qiu Y, Ping P, Xuan YT, Jones WK, Takano H, Guo Y, and Zhang J. The nitric oxide hypothesis of late preconditioning. Basic Res Cardiol 93: 325-338, 1998.
4. Bolli R, Manchikalapudi S, Tang XL, Takano H, Qiu Y, Guo Y, Zhang Q, and Jadoon AK. The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase: evidence that nitric oxide acts both as a trigger and as a mediator of the late phase of ischemic preconditioning. Circ Res 81: 1094-1107, 1997.
5. Bolli R, Shinmura K, Tang XL, Kodani E, Xuan YT, Guo Y, and Dawn B. Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning. Cardiovasc Res 55: 506-519, 2002.
6. Cason BA, Gamperl AK, Slocum RE, and Hickey RF. Anesthetic-induced preconditioning: previous administration of isoflurane decreases myocardial infarct size in rabbits. Anesthesiology 87: 1182-1190, 1997.
7. Cope DK, Impastato WK, Cohen MV, and Downey JM. Volatile anesthetics protect the ischemic rabbit myocardium from infarction. Anesthesiology 86: 699-709, 1997.
8. Davis RF and Sidi A. Effect of isoflurane on the extent of myocardial necrosis and on systemic hemodynamics, regional myocardial blood flow, and regional myocardial metabolism in dogs after coronary artery occlusion. Anesth Analg 69: 575-586, 1989.
9. Garvey EP, Oplinger JA, Furfine ES, Kiff RJ, Laszlo F, Whittle BJ, and Knowles RG. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem 272: 4959-4963, 1997.
10. Guo Y, Jones WK, Xuan YT, Tang XL, Bao W, Wu WJ, Han H, Laubach VE, Ping P, Yang Z, Qiu Y, and Bolli R. The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proc Natl Acad Sci USA 96: 11507-11512, 1999.
11. Imagawa J, Yellon DM, and Baxter GF. Pharmacological evidence that inducible nitric oxide synthase is a mediator of delayed preconditioning. Br J Pharmacol 126: 701-708, 1999.
12. Jones WK, Flaherty MP, Tang XL, Takano H, Qiu Y, Banerjee S, Smith T, and Bolli R. Ischemic preconditioning increases iNOS transcript levels in conscious rabbits via a nitric oxide-dependent mechanism. J Mol Cell Cardiol 31: 1469-1481, 1999.
13. Kapinya KJ, Löwl D, Fütterer C, Maurer M, Waschke KF, Isaev NK, and Dirnagl U. Tolerance against ischemic neuronal injury can be induced by volatile anesthetics and is inducible NO synthase dependent. Stroke 33: 1889-1898, 2002.
14. Kehl F, Pagel PS, Krolikowski JG, Gu W, Toller W, Warltier DC, and Kersten JR. Isoflurane does not produce a second window of preconditioning against myocardial infarction in vivo. Anesth Analg 95: 1162-1168, 2002.
15. ATP) channels. Anesthesiology 85: 794-807, 1996.
16. ATP channels: reduction of myocardial infarct size with an acute memory phase. Anesthesiology 87: 361-370, 1997.
17. Kuzuya T, Hoshida S, Yamashita N, Fuji H, Oe H, Hori M, Kamada T, and Tada M. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res 72: 1293-1299, 1993.
18. Ludwig LM, Weihrauch D, Kersten JR, Pagel PS, and Warltier DC. Protein kinase C translocation and Src protein tyrosine kinase activation mediate isoflurane-induced preconditioning in vivo: potential downstream targets of mitochondrial adenosine triphosphate-sensitive potassium channels and reactive oxygen species. Anesthesiology 100: 532-539, 2004.
19. Marber MS, Latchman DS, Walker JM, and Yellon DM. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 88: 1264-1272, 1993.
20. Murry CE, Jenning RB, and Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136, 1986.
21. National Research Council. Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academic Press, 1996.
22. Novalija E, Kevin LG, Camara AK, Bosnjak ZJ, Kampine JP, and Stowe DF. Reactive oxygen species precede the ε-isoform of protein kinase C in the anesthetic precondition signaling cascade. Anesthesiology 99: 421-428, 2003.
23. Oguchi T, Kashimoto S, Yamaguchi T, Nakamura T, and Kumazawa T. Comparative effects of halothane, enflurane, isoflurane and sevoflurane on function and metabolism in the ischaemic rat heart. Br J Anaesth 74: 569-575, 1995.
24. Piriou V, Chiari P, Knezynski S, Bastien O, Loufoua J, Lehot JJ, Foex P, Annat G, and Ovize M. Prevention of isoflurane-induced preconditioning by 5-hydroxydecanoate and gadolinium: possible involvement of mitochondrial adenosine triphosphate-sensitive potassium and stretch-activated channels. Anesthesiology 93: 756-764, 2000.
25. Quasha AL, Eger E III, and Tinker JH. Determination and applications of MAC. Anesthesiology 53: 315-334, 1980.
26. Shi Y, Hutchins WC, Su J, Siker D, Hogg N, Pritchard KA Jr, Keszler A, Tweddell JS, and Baker JE. Delayed cardioprotection with isoflurane: role of reactive oxygen and nitrogen. Am J Physiol Heart Circ Physiol 288: H175-H184, 2005.
27. Shinmura K, Xuan YT, Tang XL, Kodani E, Han H, Zhu Y, and Bolli R. Inducible nitric oxide synthase modulates cyclooxygenase-2 activity in the heart of conscious rabbits during the late phase of ischemic preconditioning. Circ Res 90: 602-608, 2002.
28. Takano H, Manchikalapudi S, Tang XL, Qiu Y, Rizvi A, Jadoon AK, Zhang Q, and Bolli R. Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits. Circulation 98: 441-449, 1998.
29. Tanaka K, Ludwig LM, Krolikowski JG, Alcindor D, Pratt PF, Kersten JR, Pagel PS, and Warltier DC. Isoflurane produces delayed preconditioning against myocardial ischemia and reperfusion injury: role of cyclooxygenase-2. Anesthesiology 100: 525-531, 2004.
30. ATP channels. Am J Physiol Heart Circ Physiol 283: H61-H68, 2002.
31. ATP channels and protein kinase C in ischaemic preconditioning. Clin Exp Pharmacol Physiol 30: 426-436, 2003.
32. + channel-dependent and -independent mechanisms. Anesthesiology 100: 515-524, 2004.
33. Wang Y, Kodani E, Wang J, Zhang SX, Takano H, Tang XL, and Bolli R. Cardioprotection during the final stage of the late phase of ischemic preconditioning is mediated by neuronal NO synthase in concert with cyclooxygenase-2. Circ Res 95: 84-91, 2004.
34. Yellon DM and Baxter GF. A "second window of protection" or delayed preconditioning phenomenon: future horizons for myocardial protection? J Mol Cell Cardiol 27: 1023-1034, 1995.